Loading

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support

PeerCurrent

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Clinical trial

NCT07368998

1 development in the corpus

NCT07368998

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials1 Reviews Guidelines

Latest

Everything in the corpus, newest first.

SEP 4, 2026 · PHASE 2 TRIAL

To Study the Effect of Inavolisib in Combination With Fulvestrant in Participants With Breast Cancer

ClinicalTrials.gov

This is a Phase 2 interventional trial currently recruiting; no results are posted in this registry record, making it an early-stage study with unknown efficacy and safety outcomes.

PreliminaryNCT07368998 Inavolisib Fulvestrant

Reported

Planned enrollment80

Study phasePhase 2

Primary outcome measure 1Percentage of Participants With Objective R…

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support